未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Correlation between collagen peptides and physical features of fibrosis in breast tissue from women at increased risk of cancer Rujchanarong, Denys; Stopeck, Alison T.; Preece, Christina; Sun, Ren; Chalasani, Pavani; Brown, Sean; Bai, Ji D.; Smith, Heather Jensen; You, Sungyong; Angel, Peggi M.; Thompson, Patricia 分享 收藏
分享 收藏
分享 收藏
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib Coombes, R. Charles; Howell, Sacha; Lord, Simon R.; Kenny, Laura; Mansi, Janine; Mitri, Zahi; Palmieri, Carlo; Chap, Linnea I.; Richards, Paul; Gradishar, William; Sardesai, Sagar; Melear, Jason; O'Shaughnessy, Joyce; Ward, Patrick; Chalasani, Pavani; Arkenau, Tobias; Baird, Richard D.; Jeselsohn, Rinath; Ali, Simak; Clack, Glen; Bahl, Ashwani; McIntosh, Stuart; Krebs, Matthew G. 分享 收藏
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study 新型Anti-HER2抗体-药物偶联物 (PF-06804103) 在HER2-Expressing实体瘤患者中的安全性和耐受性: 1期剂量递增研究 Meric-Bernstam, Funda; Calvo, Emiliano; Lee, Keun Seok; Moreno, Victor; Park, Yeon Hee; Rha, Sun Young; Chalasani, Pavani; Zhong, Wei; Zhou, Li; Pirie-Shepherd, Steven; Leung, Abraham C. F.; Curigliano, Giuseppe 分享 收藏
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+Breast Cancer Shagisultanova, Elena; Gradishar, William; Brown-Glaberman, Ursa; Chalasani, Pavani; Brenner, Andrew J.; Stopeck, Alison; Parris, Hannah; Gao, Dexiang; McSpadden, Tessa; Mayordomo, Jose; Diamond, Jennifer R.; Kabos, Peter; Borges, Virginia F. 分享 收藏
分享 收藏
Oxylipins as Biomarkers for Aromatase Inhibitor-Induced Arthralgia (AIA) in Breast Cancer Patients Martinez, Jessica A.; Wertheim, Betsy C.; Roe, Denise J.; Taljanovic, Mihra S.; Chow, H-H. Sherry; Chew, Wade; Ehsani, Sima; Jiralerspong, Sao; Segar, Jennifer; Chalasani, Pavani 分享 收藏
High levels of RSK2 in breast cancer patients is associated with longer PFS in patients treated with PMD-026, a first in class RSK inhibitor Wang, Judy S.; Beeram, Muralidhar; Chalasani, Pavani; Mina, Lida; Shatsky, Rebecca A.; Hurvitz, Sara; Trivedi, Meghna S.; Wesolowski, Robert; Han, Hyo S.; Patnaik, Amita; Bahadur, Shakeela; Huynh, My-My; Jayanthan, Aarthi; Los, Gerrit; Dunn, Sandra E.; Dorr, Andrew 分享 收藏
分享 收藏
Physician Practice Patterns of Breast Imaging After Treatment: Survey of Real-World Practice Whittaker, Meredith; Farr, Kiah; Potluri, Preethika; Foster, Nova; Erdrich, Jennifer; Segar, Jennifer; Ehsani, Sima; Jiralerspong, Sao; Roe, Denise; Chalasani, Pavani 分享 收藏
分享 收藏
ZN-c5, an oral selective estrogen receptor degrader (SERD), in women with advanced estrogen receptor-positive (ER plus )/human epidermal growth factor receptor 2 negative (HER2-) breast cancer Kalinksy, Kevin; Abramson, Vandana; Chalasani, Pavani; Linden, Hannah M.; Alidzanovic, Jasmina; Layman, Rachel M.; Vranjes, Zivko; Nangia, Julie R.; Crew, Katherine D.; Andric, Zoran; Milovic-Kovacevic, Marijana; Trifunovic, Jasna; Suarez, Jose; Suster, Matt; Ptaszynski, Mieke; Mortimer, Joanne 分享 收藏
Study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in combination with fulvestrant in patients with advanced hormone receptor positive HER2 negative breast cancer (HR plus BC) Coombes, Charles; Howell, Sasha J.; Krebs, Matthew G.; Lord, Simon; Kenny, Laura M.; Bahl, Ash; Clack, Glen; Ainscow, Edward; Dickinson, Paul A.; Fostea, Raluca; Mansi, Janine; Palmieri, Carlo; Bertelli, Gianflippo; Jeselsohn, Rinath; Mitri, Zahi; Gradishar, William J.; Sardesai, Sagar; O'Shaughnessy, Joyce; Ward, Patrick; Chalasani, Pavani; Lehnert, Manfred; Ali, Simak; McIntosh, Stuart 分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
Psycho-Oncology.png)
.png){kind=icon}
分享.png){kind=icon}
收藏